Please use this identifier to cite or link to this item: https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6078
Full metadata record
DC FieldValueLanguage
dc.contributor.authorC. Uday Bhanu-
dc.date.accessioned2026-02-26T07:21:53Z-
dc.date.available2026-02-26T07:21:53Z-
dc.date.issued2014-
dc.identifier.urihttps://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6078-
dc.description.abstractOne of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy (CAN), which encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, and causes denervation resulting in abnormalities in heart rate control and vascular dynamics.The present report discusses the clinical manifestations resting tachycardia, orthostasis, exercise intolerance, dizziness in the presence of CAN. It also demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes. Advances in technology, built on decades of research and clinical testing, now make it possible to objectively identify early stages of CAN with the use of careful measurement of autonomic function and to provide therapeutic choices that are based on symptom control and that might abrogate the underlying disorden_US
dc.language.isoenen_US
dc.publisherBLDE (Deemed to be university)en_US
dc.subjectParasympathetic,Sympathetic,Cardiovascular autonomic function tests,denervation,HbA1c.en_US
dc.titlePREVELANCE OF CARDIAC AUTONOMIC NEUROPATHY IN TYPE II DIABETES MELLITUSen_US
dc.typeOtheren_US
Appears in Collections:Department of General Medicine

Files in This Item:
File Description SizeFormat 
Dr. C. Uday Bhanu 2014.pdf1.22 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.